Literature DB >> 10861638

93G, a novel sporadic strain of hepatitis E virus in South China isolated by cell culture.

S Wei1, P Walsh, R Huang, S S To.   

Abstract

The nucleotide sequence of Hepatitis E virus (HEV) serous isolates (G-9 and G-20) from Guangzhou, South China, which has been reported previously, are divergent significantly from those of other reported HEV isolates. In order to investigate more extensively the Guangzhou isolate, the 93G strain was isolated from the faecal sample of the same individual as G-9 by A549 cell culture and identified immunologically and by molecular biological techniques. The results showed that strain 93G could be propagated in an A549 cell line causing cytopathic effects. The viral particles were aggregated by a specific antibody to HEV Chinese Xinjiang strain (87A) observed using immunoelectron microscopy and were similar morphologically to HEV from other sources. In this study, an indirect fluorescent antibody assay was first developed to examine HEV antigen in the infected cells, by immunofluorescence in the cytoplasm and on the surface membrane of the cells. The 58-kDa and 82-kDa native structural proteins of HEV were also identified in this study by Western blotting. The 93G genome showed high homology (93%) with G-9 previously reported but was also as divergent from the Burmese, Mexican, Chinese Xinjiang isolates and the recently reported US-1 isolate, as was G-9. The data presented indicate that 93G propagated in A549 cells, together with its related serum isolate G-9, represents another HEV strain circulating in China and is responsible for some sporadic hepatitis E infections. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861638     DOI: 10.1002/1096-9071(200007)61:3<311::aid-jmv5>3.0.co;2-h

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

Review 1.  Potential Approaches to Assess the Infectivity of Hepatitis E Virus in Pork Products: A Review.

Authors:  Nigel Cook; Martin D'Agostino; Reimar Johne
Journal:  Food Environ Virol       Date:  2017-05-03       Impact factor: 2.778

2.  N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.

Authors:  Wei Tao; Hai-Qun Zheng; Ting Fu; Zhuo-Jing He; Yan Hong
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

3.  In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein.

Authors:  Suzanne U Emerson; Hanh Nguyen; Judith Graff; David A Stephany; Alicia Brockington; Robert H Purcell
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 4.  Molecular biology and pathogenesis of hepatitis E virus.

Authors:  Vivek Chandra; Shikha Taneja; Manjula Kalia; Shahid Jameel
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

5.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

6.  Identification of genotype 4 Hepatitis E virus binding proteins on swine liver cells.

Authors:  Wen Zhang; Xiuguo Hua; Quan Shen; Shixing Yang; Hong Yin; Li Cui
Journal:  Virol J       Date:  2011-10-27       Impact factor: 4.099

Review 7.  Molecular Biology and Infection of Hepatitis E Virus.

Authors:  Yuchen Nan; Yan-Jin Zhang
Journal:  Front Microbiol       Date:  2016-09-07       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.